2310 related articles for article (PubMed ID: 8270603)
1. Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice.
Tode T; Kikuchi Y; Kita T; Hirata J; Imaizumi E; Nagata I
J Cancer Res Clin Oncol; 1993; 120(1-2):24-6. PubMed ID: 8270603
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells.
Nakata H; Kikuchi Y; Tode T; Hirata J; Kita T; Ishii K; Kudoh K; Nagata I; Shinomiya N
Jpn J Cancer Res; 1998 Jul; 89(7):733-40. PubMed ID: 9738980
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effects of oral administration of ginsenoside Rh2 on tumor growth in nude mice bearing serous cyst adenocarcinoma of the human ovary].
Tode T; Kikuchi Y; Hirata J; Kita T; Imaizumi E; Nagata I
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1275-82. PubMed ID: 8258727
[TBL] [Abstract][Full Text] [Related]
4. [In vitro and in vivo effects of ginsenoside Rh2 on the proliferation of serous cystadenocarcinoma of the human ovary].
Tode T; Kikuchi Y; Sasa H; Hirata J; Kita T; Imaizumi E; Nagata I
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):589-94. PubMed ID: 1619319
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo.
Kikuchi Y; Sasa H; Kita T; Hirata J; Tode T; Nagata I
Anticancer Drugs; 1991 Feb; 2(1):63-7. PubMed ID: 1958854
[TBL] [Abstract][Full Text] [Related]
6. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].
Hu S; Hu CP; Liang CH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030
[TBL] [Abstract][Full Text] [Related]
7. [Differentiation of B16 melanoma cells induced by ginsenoside RH2].
Xia LJ; Han R
Yao Xue Xue Bao; 1996; 31(10):742-5. PubMed ID: 9863241
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng.
Mochizuki M; Yoo YC; Matsuzawa K; Sato K; Saiki I; Tono-oka S; Samukawa K; Azuma I
Biol Pharm Bull; 1995 Sep; 18(9):1197-202. PubMed ID: 8845804
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside-Rh1 and Rh2 inhibit the induction of nitric oxide synthesis in murine peritoneal macrophages.
Park YC; Lee CH; Kang HS; Kim KW; Chung HT; Kim HD
Biochem Mol Biol Int; 1996 Nov; 40(4):751-7. PubMed ID: 8950033
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rh2 and Rh3 induce differentiation of HL-60 cells into granulocytes: modulation of protein kinase C isoforms during differentiation by ginsenoside Rh2.
Kim YS; Kim DS; Kim SI
Int J Biochem Cell Biol; 1998 Mar; 30(3):327-38. PubMed ID: 9611775
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rh2 reduces ischemic brain injury in rats.
Park EK; Choo MK; Oh JK; Ryu JH; Kim DH
Biol Pharm Bull; 2004 Mar; 27(3):433-6. PubMed ID: 14993818
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of ginsenoside Rh2: uptake and metabolism of ginsenoside Rh2 by cultured B16 melanoma cells.
Ota T; Maeda M; Odashima S
J Pharm Sci; 1991 Dec; 80(12):1141-6. PubMed ID: 1815072
[TBL] [Abstract][Full Text] [Related]
13. In vitro induction of differentiation by ginsenoides in F9 teratocarcinoma cells.
Lee YN; Lee HY; Chung HY; Kim SI; Lee SK; Park BC; Kim KW
Eur J Cancer; 1996 Jul; 32A(8):1420-8. PubMed ID: 8869109
[TBL] [Abstract][Full Text] [Related]
14. [Induction of phenotypic reverse transformation by plant glycosides in cultured cancer cells].
Odashima S; Ota T; Fujikawa-Yamamoto K; Abe H
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1483-9. PubMed ID: 2658830
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacological study on Panax ginseng C. A. Meyer. XV. Effects of 70% methanolic extract from red and white ginseng on the antitumor activity of mitomycin C].
Tong CN; Matsuda H; Kubo M
Yakugaku Zasshi; 1992 Nov; 112(11):856-65. PubMed ID: 1484351
[TBL] [Abstract][Full Text] [Related]
16. Modulation of protein kinase C activity in NIH 3T3 cells by plant glycosides from Panax ginseng.
Byun BH; Shin I; Yoon YS; Kim SI; Joe CO
Planta Med; 1997 Oct; 63(5):389-92. PubMed ID: 9342939
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of oral bioavailability and immune response of Ginsenoside Rh2 by co-administration with piperine.
Jin ZH; Qiu W; Liu H; Jiang XH; Wang L
Chin J Nat Med; 2018 Feb; 16(2):143-149. PubMed ID: 29455730
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of Korean red ginseng and its genuine constituents ginsenosides Rg3, Rf, and Rh2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models.
Bae EA; Han MJ; Shin YW; Kim DH
Biol Pharm Bull; 2006 Sep; 29(9):1862-7. PubMed ID: 16946499
[TBL] [Abstract][Full Text] [Related]
19. Generation of ginsenosides Rg3 and Rh2 from North American ginseng.
Popovich DG; Kitts DD
Phytochemistry; 2004 Feb; 65(3):337-44. PubMed ID: 14751305
[TBL] [Abstract][Full Text] [Related]
20. Antitumoral Activity of (20R)- and (20S)-Ginsenoside Rh2 on Transplanted Hepatocellular Carcinoma in Mice.
Lv Q; Rong N; Liu LJ; Xu XL; Liu JT; Jin FX; Wang CM
Planta Med; 2016 May; 82(8):705-11. PubMed ID: 27163230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
